Skip to main content Help with accessibility Skip to main navigation

LOXAPINE inhalation powder (Adasuve®▼)

CCG Approval Status:

Date Added: 21 - Jun - 2018
Body System:
Grey

The Pan Mersey Area Prescribing Committee does not currently recommend the prescribing of LOXAPINE inhalation powder (Adasuve®▼) for mild-to-moderate agitation in adult patients with schizophrenia or bipolar disorder.